PCNT — Point of Care Nano-Technology Income Statement
0.000.00%
HealthcareHighly SpeculativeMicro Cap
Annual income statement for Point of Care Nano-Technology, fiscal year end - July 31st, USD millions except per share, conversion factor applied.
2014 July 31st | 2015 July 31st | 2020 July 31st | 2021 July 31st | 2022 July 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | PROSPECTUS/A | PROSPECTUS/A | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0 | 0 | 0 | 0 | 0.01 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 0.172 | 119 | 0.013 | 0.007 | 0.074 |
Operating Profit | -0.172 | -119 | -0.013 | -0.007 | -0.064 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -0.189 | -119 | -0.013 | -0.007 | -0.064 |
Provision for Income Taxes | |||||
Net Income After Taxes | -0.189 | -119 | -0.013 | -0.007 | -0.064 |
Net Income Before Extraordinary Items | |||||
Net Income | -0.189 | -119 | -0.013 | -0.007 | -0.064 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -0.189 | -119 | -0.013 | -0.007 | -0.064 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.551 | -200 | -0.014 | -0.008 | -0.081 |